标题
New investigational drugs for the treatment of neuropathic pain
作者
关键词
-
出版物
EXPERT OPINION ON INVESTIGATIONAL DRUGS
Volume 23, Issue 8, Pages 1093-1104
出版商
Informa Healthcare
发表日期
2014-06-04
DOI
10.1517/13543784.2014.916688
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Targeting novel peripheral mediators for the treatment of chronic pain
- (2013) N Richards et al. BRITISH JOURNAL OF ANAESTHESIA
- Neuropathic pain in cancer
- (2013) M.T. Fallon BRITISH JOURNAL OF ANAESTHESIA
- Effect of Subpressor Dose of Angiotensin II on Pain-Related Behavior in Relation with Neuronal Injury and Activation of Satellite Glial Cells in the Rat Dorsal Root Ganglia
- (2013) Jaroslav Pavel et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Transient Receptor Potential Channels - Emerging Novel Drug Targets for the Treatment of Pain
- (2013) Kinga Salat et al. CURRENT MEDICINAL CHEMISTRY
- Pathophysiology of pain
- (2013) Mary Beth Babos et al. DM DISEASE-A-MONTH
- The design and discovery of T-type calcium channel inhibitors for the treatment of central nervous system disorders
- (2013) Kee-Hyun Choi Expert Opinion on Drug Discovery
- Z160: A potent and state-dependent, small molecule blocker of N-type calcium channels effective in nonclinical models of neuropathic pain
- (2013) M. Lee et al. JOURNAL OF PAIN
- Angiotensin II Produces Nociceptive Behavior through Spinal AT1 Receptor-Mediated p38 Mitogen-Activated Protein Kinase Activation in Mice
- (2013) Wataru Nemoto et al. Molecular Pain
- Voltage gated sodium and calcium channel blockers for the treatment of chronic inflammatory pain
- (2013) Wahida Rahman et al. NEUROSCIENCE LETTERS
- Nerve growth factor: an update on the science and therapy
- (2013) M.F. Seidel et al. OSTEOARTHRITIS AND CARTILAGE
- Efficacy, safety, and tolerability of fulranumab, an anti-nerve growth factor antibody, in the treatment of patients with moderate to severe osteoarthritis pain
- (2013) Panna Sanga et al. PAIN
- Small Molecule Angiotensin II Type 2 Receptor (AT2R) Antagonists as Novel Analgesics for Neuropathic Pain: Comparative Pharmacokinetics, Radioligand Binding, and Efficacy in Rats
- (2013) Maree T. Smith et al. PAIN MEDICINE
- A Small Molecule Angiotensin II Type 2 Receptor (AT2R) Antagonist Produces Analgesia in a Rat Model of Neuropathic Pain by Inhibition of p38 Mitogen-Activated Protein Kinase (MAPK) and p44/p42 MAPK Activation in the Dorsal Root Ganglia
- (2013) Maree T. Smith et al. PAIN MEDICINE
- Functional genomics of pain in analgesic drug development and therapy
- (2013) Jörn Lötsch et al. PHARMACOLOGY & THERAPEUTICS
- Novel design for a phase IIa placebo-controlled, double-blind randomized withdrawal study to evaluate the safety and efficacy of CNV1014802 in patients with trigeminal neuralgia
- (2013) Joanna M Zakrzewska et al. Trials
- Genes and epigenetic processes as prospective pain targets
- (2013) Megan Crow et al. Genome Medicine
- Neurological perspectives on voltage-gated sodium channels
- (2012) N. Eijkelkamp et al. BRAIN
- Targeting voltage-gated calcium channels: developments in peptide and small-molecule inhibitors for the treatment of neuropathic pain
- (2012) S Vink et al. BRITISH JOURNAL OF PHARMACOLOGY
- Human Mendelian pain disorders: a key to discovery and validation of novel analgesics
- (2012) YP Goldberg et al. CLINICAL GENETICS
- Angiotensin II type 2 receptor (AT2R) localization and antagonist-mediated inhibition of capsaicin responses and neurite outgrowth in human and rat sensory neurons
- (2012) U. Anand et al. EUROPEAN JOURNAL OF PAIN
- Noradrenergic reuptake inhibition in the treatment of pain
- (2012) Craig T Hartrick EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Targeting TRPV1 for pain relief: limits, losers and laurels
- (2012) Arpad Szallasi et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Ion channel drug discovery: challenges and future directions
- (2012) A Wickenden et al. Future Medicinal Chemistry
- Latest advances in novel cannabinoid CB2ligands for drug abuse and their therapeutic potential
- (2012) Peng Yang et al. Future Medicinal Chemistry
- Nerve growth factor-mediated regulation of pain signalling and proposed new intervention strategies in clinical pain management
- (2012) Laura McKelvey et al. JOURNAL OF NEUROCHEMISTRY
- Presynaptic CaV3.2 Channels Regulate Excitatory Neurotransmission in Nociceptive Dorsal Horn Neurons
- (2012) M. O. Jacus et al. JOURNAL OF NEUROSCIENCE
- Activation of Src Family Kinases in Spinal Microglia Contributes to Formalin-Induced Persistent Pain State Through p38 Pathway
- (2012) Yong-Hui Tan et al. JOURNAL OF PAIN
- T-Type Calcium Channel Blockers That Attenuate Thalamic Burst Firing and Suppress Absence Seizures
- (2012) E. Tringham et al. Science Translational Medicine
- NGF – the TrkA to successful pain treatment
- (2012) Vinayak Kumar et al. Journal of Pain Research
- T-type voltage-gated calcium channels as targets for the development of novel pain therapies
- (2011) Slobodan M Todorovic et al. BRITISH JOURNAL OF PHARMACOLOGY
- Targeting voltage-gated calcium channels for the treatment of neuropathic pain: a review of drug development
- (2011) Terry Pexton et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- A new definition of neuropathic pain
- (2011) Troels S. Jensen et al. PAIN
- Treatment of Nav1.7-mediated pain in inherited erythromelalgia using a novel sodium channel blocker
- (2011) Yigal Paul Goldberg et al. PAIN
- Recent Developments Regarding Voltage-Gated Sodium Channel Blockers for the Treatment of Inherited and Acquired Neuropathic Pain Syndromes
- (2011) Jonathan W. Theile et al. Frontiers in Pharmacology
- Pharmacogenetics of new analgesics
- (2010) Jörn Lötsch et al. BRITISH JOURNAL OF PHARMACOLOGY
- Topical capsaicin. The fire of a ‘hot’ medicine is reignited
- (2010) Alexandru DP Papoiu et al. EXPERT OPINION ON PHARMACOTHERAPY
- Ion channel blockers for the treatment of neuropathic pain
- (2010) Elena Colombo et al. Future Medicinal Chemistry
- The discovery and development of analgesics: new mechanisms, new modalities
- (2010) Gillian Burgess et al. JOURNAL OF CLINICAL INVESTIGATION
- Voltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders
- (2010) Massimo Mantegazza et al. LANCET NEUROLOGY
- A-887826 is a structurally novel, potent and voltage-dependent Nav1.8 sodium channel blocker that attenuates neuropathic tactile allodynia in rats
- (2010) Xu-Feng Zhang et al. NEUROPHARMACOLOGY
- Future Directions in Neuropathic Pain Therapy: Closing the Translational Loop
- (2010) M. Backonja et al. ONCOLOGIST
- NeuPSIG guidelines on neuropathic pain assessment
- (2010) Maija Haanpää et al. PAIN
- Sodium channel blockers for the treatment of neuropathic pain
- (2009) Anindya Bhattacharya et al. Neurotherapeutics
- Targeting voltage-gated calcium channels for neuropathic pain management
- (2009) Danielle Perret et al. Neurotherapeutics
- Targeting Nerve Growth Factor in Pain
- (2008) Judy J Watson et al. BIODRUGS
- Expression and transport of Angiotensin II AT1 receptors in spinal cord, dorsal root ganglia and sciatic nerve of the rat
- (2008) Jaroslav Pavel et al. BRAIN RESEARCH
- Voltage-gated sodium channels in pain states: Role in pathophysiology and targets for treatment
- (2008) Sulayman D. Dib-Hajj et al. BRAIN RESEARCH REVIEWS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now